Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
基本信息
- 批准号:10525056
- 负责人:
- 金额:$ 15.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-11 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
SUMMARY: The majority of HNSCC patients die from local recurrences and/or metastasis that can occur early,
or many years after primary tumor removal. This can be due to disseminated tumor cells (DTCs) remaining
dormant in patients. DTCs can be detected in the bone marrow (BM), but rarely give rise to metastasis,
suggesting a dormant state in this site. We discovered that dormancy of HNSCC DTCs precedes metastasis
and that dormant DTCs are governed by unique chromatin states and microenvironmental cues that can be
derived from the vascular niche. Through loss-of-function screens, we also identified chromatin remodelers
that enforce tumor cell dormancy. Further, using information we derived from senescence models, we
determined that dormant DTCs express chromatin regulators and secreted factors found in senescent cells.
We hypothesize that specific microenvironmental cues and epigenetic regulators induce and maintain
a strong, yet reversible, growth arrest program during the dormant state of DTCs. We found that the
quiescence and differentiation signals, retinoic acid (atRA), TGF2 and BMP7 can induce dormancy and
metastasis suppression. Dormant cancer cells also display a global repressive chromatin state and
upregulation of specific transcription factors (NR2F1) and histone variants (macroH2A, clipped H3.3), found
upregulated during differentiation, senescence and metastasis suppression. In addition, CRISPR-Cas9
screens identified the chromatin remodeler ARID1A as an enforcer of dormancy. We propose that
microenvironmental and epigenetic regulators converge to induce and maintain dormancy. We will test this
hypothesis by A) investigating the role of histone variant macroH2A associated with quiescence and
senescence programs in DTC dormancy induction, B) deciphering how ARID1A enforces dormancy and C)
by identifying chromatin permissive states for dormancy induction by microenviromental signals. MPI
SYNERGY: The Aguirre-Ghiso and Bernstein labs along with our collaborators have a productive history of
publications and active collaborations. This team possesses specialized expertise in dormancy, metastasis,
and chromatin biology that has delivered breakthroughs in the cancer dormancy and metastasis fields. The
Condeelis team will provide the most advanced intravital imaging to dissect the epigenetic and
microenvironmental regulation of DTC dormancy onset and survival at single cell resolution. Importantly, the
Klein and Stoecklein labs will allow validation of our findings in human DTC samples. This provides an
unsurpassed opportunity to dissect the microenvironmental and epigenetic regulation of single DTC dormancy.
摘要:大多数HNSCC患者死于早期的局部复发和/或转移。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
- DOI:10.1016/j.celrep.2023.112560
- 发表时间:2023-06-27
- 期刊:
- 影响因子:8.8
- 作者:
- 通讯作者:
How dormant cancer persists and reawakens.
- DOI:10.1126/science.aav0191
- 发表时间:2018-09-28
- 期刊:
- 影响因子:0
- 作者:Aguirre-Ghiso JA
- 通讯作者:Aguirre-Ghiso JA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julio A. Aguirre-Ghiso其他文献
Models, mechanisms and clinical evidence for cancer dormancy
癌症休眠的模型、机制和临床证据
- DOI:
10.1038/nrc2256 - 发表时间:
2007-11-01 - 期刊:
- 影响因子:66.800
- 作者:
Julio A. Aguirre-Ghiso - 通讯作者:
Julio A. Aguirre-Ghiso
Targeting PERK Arm of Unfolded Protein Response Helps to Eliminate Therapy-Induced Residual Senescent-like Acute Myeloid Leukemia Cells
- DOI:
10.1182/blood-2024-203451 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Gowri Poigaialwar;Sumiko Takao;Sovira Chaudhry;Laura K. Schmalbrock;Varun Gupta;Alex Kentsis;Julio A. Aguirre-Ghiso;Marina Konopleva;Maria S. Sosa;Anna Skwarska - 通讯作者:
Anna Skwarska
Julio A. Aguirre-Ghiso的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julio A. Aguirre-Ghiso', 18)}}的其他基金
Immune Regulation of Disseminated Cancer Cell Dormancy
播散性癌细胞休眠的免疫调节
- 批准号:
10201082 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
Immune Regulation of Disseminated Cancer Cell Dormancy
播散性癌细胞休眠的免疫调节
- 批准号:
10513907 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
- 批准号:
10645058 - 财政年份:2020
- 资助金额:
$ 15.09万 - 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
- 批准号:
10226338 - 财政年份:2020
- 资助金额:
$ 15.09万 - 项目类别:
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
葡萄膜黑色素瘤休眠机制及靶向治疗耐受性
- 批准号:
10414811 - 财政年份:2020
- 资助金额:
$ 15.09万 - 项目类别:
Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
- 批准号:
9924485 - 财政年份:2017
- 资助金额:
$ 15.09万 - 项目类别:
Epigenetic and microenvironmental regulation of dormant disseminated cancer
休眠播散性癌症的表观遗传学和微环境调控
- 批准号:
9502259 - 财政年份:2017
- 资助金额:
$ 15.09万 - 项目类别:
相似海外基金
Cell Control via Spatiotemporal Microenvironmental pH Modulation
通过时空微环境 pH 调节进行细胞控制
- 批准号:
10713388 - 财政年份:2023
- 资助金额:
$ 15.09万 - 项目类别:
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
骨髓微环境老化机制及其对克隆造血进展的影响
- 批准号:
10539513 - 财政年份:2022
- 资助金额:
$ 15.09万 - 项目类别:
Microenvironmental drivers of indolent to aggressive prostate cancer switch mediated by combined MYC Activation and PTEN loss
MYC 激活和 PTEN 缺失联合介导的惰性前列腺癌向侵袭性前列腺癌转变的微环境驱动因素
- 批准号:
10518917 - 财政年份:2022
- 资助金额:
$ 15.09万 - 项目类别:
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
骨髓微环境衰老机制及其对克隆造血进展的影响
- 批准号:
10665803 - 财政年份:2022
- 资助金额:
$ 15.09万 - 项目类别:
Microenvironmental drivers of indolent to aggressive prostate cancer switch mediated by combined MYC Activation and PTEN loss
MYC 激活和 PTEN 缺失联合介导的惰性前列腺癌向侵袭性前列腺癌转变的微环境驱动因素
- 批准号:
10698140 - 财政年份:2022
- 资助金额:
$ 15.09万 - 项目类别:
Microenvironmental Control of Liver Progenitor Cell Differentiation and Spatial Patterning
肝祖细胞分化和空间模式的微环境控制
- 批准号:
10392459 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
Mechanisms of tumor microenvironmental regulation of T-cell infiltration in melanoma
黑色素瘤T细胞浸润的肿瘤微环境调节机制
- 批准号:
10600085 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
Defining the role of microenvironmental ammonia in colorectal cancers
定义微环境氨在结直肠癌中的作用
- 批准号:
10313531 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
Microenvironmental Control of Liver Progenitor Cell Differentiation and Spatial Patterning
肝祖细胞分化和空间模式的微环境控制
- 批准号:
10220587 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
Defining the role of microenvironmental ammonia in colorectal cancers
定义微环境氨在结直肠癌中的作用
- 批准号:
10463578 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别: